{"id":"https://openalex.org/W2809537878","doi":"https://doi.org/10.5414/cp203083","title":"The association between CYP2C9/2C19 polymorphisms and phenytoin maintenance doses in Asian epileptic patients: A systematic review and meta-analysis","display_name":"The association between CYP2C9/2C19 polymorphisms and phenytoin maintenance doses in Asian epileptic patients: A systematic review and meta-analysis","publication_year":2018,"publication_date":"2018-06-22","ids":{"openalex":"https://openalex.org/W2809537878","doi":"https://doi.org/10.5414/cp203083","mag":"2809537878","pmid":"https://pubmed.ncbi.nlm.nih.gov/29628024"},"language":"en","primary_location":{"id":"doi:10.5414/cp203083","doi":"https://doi.org/10.5414/cp203083","is_oa":false,"landing_page_url":"https://doi.org/10.5414/cp203083","pdf_url":null,"source":{"id":"https://openalex.org/S166536441","display_name":"International Journal of Clinical Pharmacology and Therapeutics","issn_l":"0946-1965","issn":["0946-1965"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","medline","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310313675","host_organization_name":"Dustri-Verlag","host_organization_lineage":["https://openalex.org/P4310313675"],"host_organization_lineage_names":["Dustri-Verlag"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Int. Journal of Clinical Pharmacology and Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101749474","display_name":"Kai Liao","orcid":"https://orcid.org/0000-0002-2037-7628","observed_orcids":["https://orcid.org/0000-0002-2037-7628"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kai Liao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5115501056","display_name":"Yong Liu","orcid":"https://orcid.org/0000-0001-9945-8131","observed_orcids":["https://orcid.org/0000-0001-9945-8131"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yong Liu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061285043","display_name":"Chun\u2010Zhi Ai","orcid":"https://orcid.org/0000-0002-4194-6690","observed_orcids":["https://orcid.org/0000-0002-4194-6690"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chun-Zhi Ai","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Xi Yu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xi Yu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5100318008","display_name":"Wei Shan Li","orcid":"https://orcid.org/0000-0001-7458-2590","observed_orcids":["https://orcid.org/0000-0001-7458-2590"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wei Li","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":5.6338,"has_fulltext":false,"cited_by_count":41,"citation_normalized_percentile":{"value":0.97546755,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"56","issue":"07","first_page":"337","last_page":"346"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.00930000003427267,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/phenytoin","display_name":"phenytoin","score":0.996999979019165},{"id":"https://openalex.org/keywords/cyp2c9-polymorphism","display_name":"CYP2C9 polymorphism","score":0.8960000276565552},{"id":"https://openalex.org/keywords/cyp2c19-polymorphism","display_name":"CYP2C19 polymorphism","score":0.9990000128746033},{"id":"https://openalex.org/keywords/maintenance-dose","display_name":"maintenance dose","score":0.777999997138977},{"id":"https://openalex.org/keywords/pharmacogenetics","display_name":"pharmacogenetics","score":0.6930000185966492},{"id":"https://openalex.org/keywords/epilepsy","display_name":"epilepsy","score":0.6460000276565552},{"id":"https://openalex.org/keywords/antiepileptic-drugs","display_name":"antiepileptic drugs","score":0.9100000262260437},{"id":"https://openalex.org/keywords/drug-metabolism","display_name":"drug metabolism","score":0.734000027179718},{"id":"https://openalex.org/keywords/asian-patients","display_name":"Asian patients","score":0.6679999828338623},{"id":"https://openalex.org/keywords/ethnic-differences","display_name":"ethnic differences","score":0.7789999842643738},{"id":"https://openalex.org/keywords/dose-adjustment","display_name":"dose adjustment","score":0.6399999856948853}],"concepts":[{"id":"https://openalex.org/C140840227","wikidata":"https://www.wikidata.org/wiki/Q3737532","display_name":"CYP2C19","level":4,"score":0.9397743940353394},{"id":"https://openalex.org/C3946865","wikidata":"https://www.wikidata.org/wiki/Q5014962","display_name":"CYP2C9","level":4,"score":0.7491368651390076},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.7272840738296509},{"id":"https://openalex.org/C2778337148","wikidata":"https://www.wikidata.org/wiki/Q410400","display_name":"Phenytoin","level":3,"score":0.609096884727478},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6006889343261719},{"id":"https://openalex.org/C27924281","wikidata":"https://www.wikidata.org/wiki/Q17126475","display_name":"Maintenance dose","level":2,"score":0.5894629955291748},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5465121865272522},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.45864230394363403},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.2942349910736084},{"id":"https://openalex.org/C526171541","wikidata":"https://www.wikidata.org/wiki/Q407693","display_name":"Cytochrome P450","level":3,"score":0.27145272493362427},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.09442257881164551},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.07048264145851135}],"mesh":[{"descriptor_ui":"D000071184","descriptor_name":"Pharmacogenomic Variants","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D004827","descriptor_name":"Epilepsy","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004827","descriptor_name":"Epilepsy","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D004827","descriptor_name":"Epilepsy","qualifier_ui":"Q000208","qualifier_name":"ethnology","is_major_topic":false},{"descriptor_ui":"D004827","descriptor_name":"Epilepsy","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D006579","descriptor_name":"Heterozygote","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006720","descriptor_name":"Homozygote","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010597","descriptor_name":"Pharmacogenetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010672","descriptor_name":"Phenytoin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D010672","descriptor_name":"Phenytoin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010672","descriptor_name":"Phenytoin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016009","descriptor_name":"Chi-Square Distribution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016903","descriptor_name":"Drug Monitoring","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020641","descriptor_name":"Polymorphism, Single Nucleotide","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D044466","descriptor_name":"Asian People","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D065729","descriptor_name":"Cytochrome P-450 CYP2C9","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D065729","descriptor_name":"Cytochrome P-450 CYP2C9","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D065731","descriptor_name":"Cytochrome P-450 CYP2C19","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D065731","descriptor_name":"Cytochrome P-450 CYP2C19","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.5414/cp203083","doi":"https://doi.org/10.5414/cp203083","is_oa":false,"landing_page_url":"https://doi.org/10.5414/cp203083","pdf_url":null,"source":{"id":"https://openalex.org/S166536441","display_name":"International Journal of Clinical Pharmacology and Therapeutics","issn_l":"0946-1965","issn":["0946-1965"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","medline","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310313675","host_organization_name":"Dustri-Verlag","host_organization_lineage":["https://openalex.org/P4310313675"],"host_organization_lineage_names":["Dustri-Verlag"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Int. Journal of Clinical Pharmacology and Therapeutics","raw_type":"journal-article"},{"id":"pmid:29628024","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29628024","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of clinical pharmacology and therapeutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[{"display_name":"Systematic Review","id":"https://openalex.org/study-designs/systematic-review"},{"display_name":"Meta-Analysis","id":"https://openalex.org/study-designs/meta-analysis"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2131933646","https://openalex.org/W2123198632","https://openalex.org/W2352580890","https://openalex.org/W2362740757","https://openalex.org/W2039860301","https://openalex.org/W2019490856","https://openalex.org/W2020797824","https://openalex.org/W4300518856","https://openalex.org/W1566463136","https://openalex.org/W2059428339"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Therapeutic":[1],"response":[2],"to":[3,18,32,46,85,94],"phenytoin":[4],"(PHT),":[5],"a":[6,165,169],"first-line":[7],"antiepileptic":[8],"drug":[9],"(AED),":[10],"is":[11,151],"highly":[12],"variable,":[13],"in":[14,23,53,61,76,120,148,196],"part":[15],"likely":[16],"due":[17],"genetic":[19,51],"factors.":[20],"Genetic":[21],"polymorphisms":[22,52,100,188],"cytochrome":[24],"P450":[25],"(CYP)":[26],"2C9":[27],"and":[28,38,78,101,125,162,186],"CYP2C19":[29,127,163,187],"are":[30,189],"expected":[31],"affect":[33,40],"the":[34,48,96,115],"metabolism":[35],"of":[36,50,108,139,172],"PHT":[37,58,102,140,173,193,204],"consequently":[39],"its":[41],"maintenance":[42,59,103,141,145,194,205],"doses.":[43,104],"We":[44],"aimed":[45],"clarify":[47],"effects":[49],"both":[54,159],"enzymes":[55],"on":[56],"daily":[57],"dosage":[60,176,195],"Asian":[62,197],"epileptic":[63,198],"patients":[64,113],"by":[65],"meta-analysis.":[66,122],"MATERIALS":[67],"AND":[68],"METHODS:":[69],"A":[70,106],"systematic":[71],"literature":[72],"search":[73],"was":[74,92,178],"conducted":[75],"PubMed":[77],"EMBASE":[79],"for":[80],"relevant":[81],"studies":[82,110],"published":[83],"prior":[84],"April":[86],"14,":[87],"2017.":[88],"RevMan":[89],"5.2.3":[90],"software":[91],"used":[93],"analyze":[95],"relationship":[97],"between":[98],"CYP2C9/2C19":[99],"RESULTS:":[105],"total":[107],"6":[109],"with":[111,155,191],"993":[112],"fulfilling":[114],"inclusion":[116],"criteria":[117],"were":[118],"included":[119],"our":[121],"The":[123,143,181],"homozygous":[124],"heterozygous":[126,156,160],"mutation":[128],"group":[129,150],"(i.e.,":[130],"CYP2C19*2/*2,":[131],"CYP2C19*3/*3,":[132],"or":[133,158],"CYP2C19*2/*3":[134],"group)":[135],"required":[136],"significant":[137],"decrease":[138,171],"dose.":[142,206],"starting":[144],"dose":[146],"suggested":[147],"this":[149],"4.38":[152],"mg/kg/day.":[153],"Patients":[154],"CYP2C9":[157,161,185],"showed":[164],"trend":[166],"but":[167,175],"not":[168],"statistically-significant":[170],"dose,":[174],"adjustment":[177],"recommended.":[179],"CONCLUSION:":[180],"meta-analysis":[182],"indicates":[183],"that":[184],"associated":[190],"lower":[192],"patients.":[199],"Ethnic":[200],"differences":[201],"can":[202],"influence":[203],".":[207]},"counts_by_year":[{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":28},{"year":2019,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2018-06-29T00:00:00"}